Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;127(3):361-368.
doi: 10.1002/jso.27115. Epub 2022 Oct 8.

A systematic review of oncological outcomes after nipple-sparing mastectomy for breast cancer

Alexandra M Zaborowski  1 , Simon Roe  1 , Jane Rothwell  1 , Denis Evoy  1 , James Geraghty  1 , Damian McCartan  1 , Ruth S Prichard  1
Affiliations

A systematic review of oncological outcomes after nipple-sparing mastectomy for breast cancer

Alexandra M Zaborowski et al. J Surg Oncol. 2023 Mar.

Abstract

Nipple-sparing mastectomy is an alternative to skin-sparing mastectomy in select patients. Increasing evidence supports its use in the setting of breast cancer, however concerns still exist regarding oncological safety. The aim of this systematic review was to evaluate long-term oncological outcomes of patients who underwent nipple-sparing mastectomy for breast cancer. A systematic review of the literature was performed to evaluate oncological outcomes in patients with breast cancer who underwent nipple-sparing mastectomy. Five major databases (PubMed, Embase, Scopus, Web of Science and Cochrane) were searched. The review included all original articles published in English reporting long-term oncological outcomes. 2334 studies were identified. After applying inclusion and exclusion criteria, 17 retrospective studies involving 7107 patients were included. The indication for nipple-sparing mastectomy was invasive carcinoma in 6069 patients (85.4%) and in situ disease in 1038 (14.6%). Median follow up was 48 months (range 25-94). The weighted mean rates of local recurrence and recurrence involving the nipple-areola complex were 5.4% (0.9-11.9) and 1.3% (0-4.9), respectively. The weighted mean distant failure rate was 4.8% (1.5-23.0). Therapeutic nipple-sparing mastectomy is oncologically safe in select patients with breast cancer.

Keywords: NSM; nipple-sparing mastectomy; skin-sparing mastectomy.

PubMed Disclaimer

References

REFERENCES

    1. Galimberti V, Vicini E, Corso G, et al. Nipple-sparing and skin-sparing mastectomy: review of aims, oncological safety and contraindications. Breast. 2017;34(suppl 1):S82-S84. doi:10.1016/j.breast.2017.06.034
    1. Freeman BS. Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plast Reconstr Surg Transplant Bull. 1962;30:676-682. doi:10.1097/00006534-196212000-00008
    1. Djohan R, Gage E, Gatherwright J, et al. Patient satisfaction following nipple-sparing mastectomy and immediate breast reconstruction: an 8-year outcome study. Plast Reconstr Surg. 2010;125(3):818-829. doi:10.1097/PRS.0b013e3181ccdaa4
    1. Didier F, Radice D, Gandini S, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality. Breast Cancer Res Treat. 2009;118(3):623-633. doi:10.1007/s10549-008-0238-4
    1. Yueh JH, Houlihan MJ, Slavin SA, Lee BT, Pories SE, Morris DJ. Nipple-sparing mastectomy: evaluation of patient satisfaction, aesthetic results, and sensation. Ann Plast Surg. 2009;62(5):586-590. doi:10.1097/SAP.0b013e31819fb1ac

Publication types

LinkOut - more resources